Litcius/Paper detail

The value of lymph nodes ratios in the prognosis of resectable remnant gastric cancer through the retrospective propensity score matching analysis

Biao Yang, Tao Liu, Hangtian Cui, Zhengmao Lu, Guoen Fang, Xuchao Xue, Tianhang Luo

2023World Journal of Surgical Oncology14 citationsDOIOpen Access PDF

Abstract

PURPOSE: Currently, the characteristics and prognosis of remnant gastric cancer (RGC) are not fully understood yet. The present study aimed to describe the details of clinicopathological features of resectable RGC and investigated the factors affecting survival after the curative operation. METHODS: From Jan. 2006 to Dec. 2015, a total of 118 resectable RGC patients (the RGC group) and 236 age-, sex- and TNM stages-matched resectable gastric cancer (GC) patients (the control group) were recruited retrospectively. Clinicopathological characteristics and overall survival were compared between the two groups. RESULTS: The overall survival rate was 46.61% for RGC patients compared to 55.08% for control groups (P < 0.01), and the mean overall survival time of RGC patients was 40.23 ± 32.27 months, compared to 55.06 ± 34.29 months in the control group (P = 0.023 after matching). The overall survival (OS) of RGC patients with stage IIb was much worse than IIa (P < 0.001) and similar to IIIa (P = 0.463) and IIIb (P = 0.014). Multivariate Cox proportional hazards model analysis revealed that TNM stage (HR: 3.899, P < 0.001) and lymph nodes ratio (LNR) (HR: 2.405, P = 0.028) were independent prognostic significance to OS. CONCLUSIONS: The OS of RGC was much worse than GC with similar TNM stages, and LNR might consider a highly reliable indicator to evaluate the prognostic in RGC.

Topics & Concepts

MedicinePropensity score matchingSurgical oncologyInternal medicineLymphStage (stratigraphy)CancerMultivariate analysisProportional hazards modelGastroenterologyRetrospective cohort studySurvival analysisSurvival rateOncologyPathologyBiologyPaleontologyGastric Cancer Management and OutcomesHelicobacter pylori-related gastroenterology studiesMultiple and Secondary Primary Cancers